Press Releases :: Cellectar Biosciences, Inc. (CLRB)

Year

Release Type

Mar 5, 2018

Cellectar Biosciences to Present at Upcoming March Conferences

Feb 8, 2018

Cellectar Biosciences to Present at the 2018 BIO CEO & Investor Conference

Feb 7, 2018

Cellectar Receives USPTO Notice of Allowance for Patent Covering Use of CLR 131 in Multiple Myeloma

Jan 29, 2018

Cellectar Initiates DLBCL Cohort in Phase 2 Trial of CLR 131 in Refractory B-Cell Hematologic Cancers